| 1 | A Biomed company aiming to leverage proprietary computational systems
including AI to
accelerate development of novel drug alternatives to life threatening
diseases like
cancer, bacterial infections and muscular dystrophy.
| AI & Drug Development | USA | $20m | IND |
| 2 | A Biomed company providing specialised rehabilitation services to treat
patients
suffering from drug addiction and opioid dependence with clinics using
therapies from a
specialised drug. The company is focused on creating a diverse real
estate portfolio
with healthcare and detox related assets whose sole purpose are to
establish turn-key
addiction recovery facilities.
| Addiction | Canada | $5m | Pre revenue |
| 3 | A Biomed company that is developing a novel therapeutic class
of
medicines that use the
body's natural immune response to decrease inflammation and stimulate
repair
mechanisms, thereby repairing the damage caused by disease and slowing
aging.
| Aging | USA | $50m | Phase 3 |
